Teacher Retirement System of Texas Has $890,000 Stake in Masimo Corporation $MASI

Teacher Retirement System of Texas reduced its holdings in Masimo Corporation (NASDAQ:MASI) by 48.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 6,033 shares of the medical equipment provider’s stock after selling 5,638 shares during the period. Teacher Retirement System of Texas’ holdings in Masimo were worth $890,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Viking Global Investors LP acquired a new stake in shares of Masimo in the second quarter valued at about $129,096,000. Westfield Capital Management Co. LP raised its stake in shares of Masimo by 75.9% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,181,203 shares of the medical equipment provider’s stock worth $198,702,000 after purchasing an additional 509,724 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Masimo by 25.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 2,470,393 shares of the medical equipment provider’s stock worth $415,570,000 after purchasing an additional 502,555 shares in the last quarter. Grantham Mayo Van Otterloo & Co. LLC acquired a new stake in shares of Masimo in the 2nd quarter valued at approximately $40,468,000. Finally, Ameriprise Financial Inc. grew its stake in shares of Masimo by 86.3% in the second quarter. Ameriprise Financial Inc. now owns 394,487 shares of the medical equipment provider’s stock valued at $66,361,000 after buying an additional 182,701 shares in the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Price Performance

Masimo stock opened at $139.13 on Wednesday. The company has a market capitalization of $7.47 billion, a price-to-earnings ratio of -13.20, a PEG ratio of 1.40 and a beta of 1.26. The company has a current ratio of 2.84, a quick ratio of 1.92 and a debt-to-equity ratio of 0.69. Masimo Corporation has a 12 month low of $125.94 and a 12 month high of $194.88. The stock’s 50 day moving average is $137.71 and its 200-day moving average is $144.06.

Masimo (NASDAQ:MASI) last released its quarterly earnings results on Tuesday, November 4th. The medical equipment provider reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.12. The business had revenue of $371.20 million during the quarter, compared to the consensus estimate of $366.89 million. Masimo had a positive return on equity of 33.04% and a negative net margin of 33.20%.The firm’s quarterly revenue was up 8.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.86 EPS. Equities research analysts expect that Masimo Corporation will post 4.1 EPS for the current year.

Analyst Ratings Changes

MASI has been the subject of a number of recent analyst reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Masimo in a research note on Thursday, January 22nd. Wall Street Zen raised shares of Masimo from a “hold” rating to a “buy” rating in a report on Tuesday, October 14th. Wells Fargo & Company reiterated an “overweight” rating and set a $190.00 price target on shares of Masimo in a report on Friday, December 5th. Bank of America assumed coverage on Masimo in a research note on Monday, November 17th. They issued a “neutral” rating and a $162.00 price objective on the stock. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a research report on Monday, December 1st. Four analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $189.40.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.